ABBATE, MARIA IDA
ABBATE, MARIA IDA
Mostra
records
Risultati 1 - 5 di 5 (tempo di esecuzione: 0.02 secondi).
Novel Therapeutic Options for Small Cell Lung Cancer
2023 Canova, S; Trevisan, B; Abbate, M; Colonese, F; Sala, L; Baggi, A; Bianchi, S; D'Agostino, A; Cortinovis, D
Harnessing DLL3 inhibition: From old promises to new therapeutic horizons
2022 Cortinovis, D; Colonese, F; Abbate, M; Sala, L; Meazza Prina, M; Cordani, N; Sala, E; Canova, S
Vanishing bile duct syndrome following pembrolizumab infusion: case report and review of the literature
2022 Gemelli, M; Carbone, M; Abbate, M; Mancin, M; Zucchini, N; Colonese, F; Invernizzi, P; Bidoli, P; Cortinovis, D
A new race against lung cancer
2017 Cortinovis, D; Canova, S; Abbate, M; Colonese, F; Bidoli, P
Focus on nivolumab in NSCLC
2016 Cortinovis, D; Canova, S; Abbate, M; Colonese, F; Bidoli, P
Titolo | Tipologia | Data di pubblicazione | Autori | File |
---|---|---|---|---|
Novel Therapeutic Options for Small Cell Lung Cancer | 01 - Articolo su rivista | 2023 | Abbate, MIBianchi, SPCortinovis, DL + | |
Harnessing DLL3 inhibition: From old promises to new therapeutic horizons | 01 - Articolo su rivista | 2022 | Cortinovis D. L.Abbate M. I.Cordani N. + | |
Vanishing bile duct syndrome following pembrolizumab infusion: case report and review of the literature | 01 - Articolo su rivista | 2022 | Carbone M.Abbate M. I.Invernizzi P.Bidoli P.Cortinovis D. + | |
A new race against lung cancer | 01 - Articolo su rivista | 2017 | Cortinovis DAbbate MIBidoli P + | |
Focus on nivolumab in NSCLC | 01 - Articolo su rivista | 2016 | Cortinovis D. L.Abbate M.Bidoli P. + |